Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3199
Selected: 0
NCT IDTitle
NCT00877773Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patients
NCT04516070Stereotactic Radiosurgery for the Treatment of Patients With Small Cell Lung Cancer Brain Metastasis
NCT00535873Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older
NCT00495170Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)
NCT051300734-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer
NCT04874194Omacetaxine and Venetoclax for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Harboring Mutant RUNX1
NCT00038675Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate
NCT04754412Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study
NCT06043323A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
NCT00439556Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant
NCT06218602Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.
NCT02804945Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With Malignancies
NCT00068575Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer
NCT02948101PD 0360324 and Cyclophosphamide in Treating Patients With Recurrent High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT00972101Infusion of Expanded Cord Blood T Cells
NCT01436227Pazopanib Hydrochloride in Treating Patients With Von Hippel-Lindau Syndrome
NCT03531645Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma
NCT04483349Assessment of What Patients and Healthcare Providers Value
NCT01068249Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer
NCT03982082Ultrasound in Evaluating Muscle-Glycogen Content in Cancer Patients
NCT00367224Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo
NCT02573766Neuromodulation as a Treatment for Chemotherapy-Induced Peripheral Neuropathy
NCT01900002Sorafenib Tosylate and Yttrium Y 90 Glass Microspheres in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
NCT06576037Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin
NCT05118295Single Step Lesion Annotation and Localization of Suspicious Breast Lesions
NCT05837039A Comparison of Healthcare Provider and Caregiver Perception of Discomfort in Advanced Cancer Patients Who Have a Hypoactive Delirium
NCT01243190Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT00505310Biobehavioral Effects of Emotional Expression in Cancer
NCT00507351Ambulatory Cancer Pain Management: A Feasibility Study
NCT03360721Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer
NCT06113302A Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic Syndromes (MDS)
NCT00957853Preoperative Treatment With Cetuximab and/or IMC-A12
NCT00003693Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
NCT02613728Accelerated Enhanced RECOVERy Following Minimally Invasive Colorectal Cancer Surgery (RecoverMI)
NCT02389764Nintedanib For HER2-Negative Metastatic Inflammatory Breast Cancer (MIBC)
NCT00473551Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies
NCT01772771Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
NCT03106077Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast Cancer
NCT02652871LY2510924, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT03132467Durvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast Cancer
NCT00429104Herceptin and GM-CSF for Metastatic Breast Cancer
NCT00427336Purine Analog-Based Conditioning in Patients With Severe Aplastic Anemia
NCT03513198Perfusion Assessment With Contrast-Enhanced EUS in Locally Advanced and Metastatic Pancreatic Cancer
NCT00469144IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome
NCT00420433Bone Response in Metastatic Breast Cancer Involving Bones
NCT00948233Project COMBAT: Combating Tobacco Use in the United States Army
NCT03581487Durvalumab, Tremelimumab, and Selumetinib in Treating Participants With Recurrent or Stage IV Non-small Cell Lung Cancer
NCT00734526Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
NCT05045963Impact of Aminoglycosides in Hypotensive Septic Oncology Patients
NCT02357134High-Flow Oxygen in Reducing Shortness of Breath Caused by Exercise in Patients With Cancer